Keyphrases
Olmesartan
100%
Urinary Albumin Excretion
100%
Calcium Channel Blockers
100%
Combination Treatment
100%
Diuretics
100%
Angiotensin Receptor Blockade
100%
Albumin-to-creatinine Ratio
71%
Hydrochlorothiazide
57%
Azelnidipine
57%
Angiotensin Receptor Blockers
57%
Systolic BP
57%
8-isoprostane
28%
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)
28%
Diuretic Combinations
28%
Insulin Resistance Index
28%
Inflammation
14%
Oxidative Stress
14%
Estimated Glomerular Filtration Rate
14%
Regression Analysis
14%
Insulin Resistance
14%
Monotherapy
14%
Prospective Randomized Trial
14%
Hypertensive Patients
14%
Nighttime Blood Pressure
14%
Percentage Reduction
14%
Ambulatory Blood Pressure
14%
High-sensitivity C-reactive Protein (hs-CRP)
14%
Central Systolic Blood Pressure
14%
Stress Urinary
14%
Central Blood Pressure
14%
Medicine and Dentistry
Urinary System
100%
Calcium Channel Blocking Agent
100%
Receptor Blocking
100%
Diuretic Agent
100%
Angiotensin Receptor
100%
Olmesartan
87%
Creatinine
62%
Angiotensin Receptor Antagonist
50%
Azelnidipine
50%
Hydrochlorothiazide
50%
Homeostatic Model Assessment
25%
Resistance Index
25%
8 Isoprostane
25%
Glomerular Filtration Rate
12%
Blood Pressure
12%
Systolic Blood Pressure
12%
Monotherapy
12%
Laboratory Test
12%
C Reactive Protein
12%
Oxidative Stress
12%
Insulin Resistance
12%
Ambulatory Blood Pressure
12%
Pharmacology, Toxicology and Pharmaceutical Science
Olmesartan
100%
Calcium Channel Blocker
100%
Diuretic Agent
100%
Angiotensin Receptor
100%
Creatinine
71%
Hydrochlorothiazide
57%
Azelnidipine
57%
Angiotensin Receptor Antagonist
57%
Insulin Resistance
42%
8 Isoprostane
28%
Inflammation
14%
Monotherapy
14%
C Reactive Protein
14%
Neuroscience
Creatinine
100%
Angiotensin Receptor
100%
Diuretic
100%
Calcium Channel Blocker
100%
Hydrochlorothiazide
80%
8 Isoprostane
40%
Oxidative Stress
20%
C-Reactive Protein
20%